FRIDAY, July 18, 2025 (HealthDay News) — After years of legal battles and health concerns, Juul Labs has the go-ahead to sell ...

JUUL GETS ITS CROWN — The FDA authorized Juul’s applications on Thursday to sell e-cigarettes in the U.S., determining ...

In a significant reversal and a major boost for the embattled vaping company, the U.S. Food and Drug Administration (FDA) on ...

The FDA decision applies to both tobacco- and menthol-flavored versions of the reusable product, which works with ...

On July 17, 2025, the U.S. Food and Drug Administration (FDA) issued Marketing Granted Orders (MGOs) to JUUL Labs Inc. (JUUL) ...

The Food and Drug Administration has authorized Juul Labs to keep its e-cigarettes on the market, a major reversal after the ...

In 2022, the FDA had made the decision to ban the products because the applications lacked sufficient evidence to show they met a public health standard.

Tayler said the FDA’s own research has highlighted that fact. “In the last National Youth Tobacco Survey, they asked youths if they used mint or menthol flavored and nearly 60% of them did,” she said.

After a 3-year ban, the FDA is permitting JUUL to sell its e-cigarettes again, citing reduced harm for adult smokers—though the agency stresses the products are not FDA-approved or risk-free.

Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.

Recent developments in the health sector highlight diverse changes from drug pricing initiatives by Bristol Myers and Pfizer ...